Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s Central Government To Invest $17 Billion In Healthcare Reform In 2009

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's Central government announced it would invest RMB 118.1 billion ($17.3 billion) for healthcare reform in 2009 during a joint working meeting April 20 with the National Development and Reform Committee, the Ministry of Health, the Ministry Of Finance, the Ministry of Human Resources and Social Security and the State FDA
Advertisement

Related Content

PharmAsia News' Top Industry Trends Of 2009
PharmAsia News' Top Industry Trends Of 2009
China’s Essential Drug System Expected To Consolidate Generic Industry, Promote Innovative R&D
China’s Essential Drug System Expected To Consolidate Generic Industry, Promote Innovative R&D
China’s Essential Drug System Expected To Consolidate Generic Industry, Promote Innovative R&D
China’s Essential Drug System Expected To Consolidate Generic Industry, Promote Innovative R&D
China Issues New Technical Guidelines For Medical Devices In Preparation For Healthcare Reform
China Issues Three-year Healthcare Reform Plan To Invest RMB 850 Billion
China Issues Three-year Healthcare Reform Plan To Invest RMB 850 Billion
Medical Device Sector Expected To Gain The Most From China’s Healthcare Reform
Advertisement
UsernamePublicRestriction

Register

SC071442

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel